A study utilizing The Cancer Genome Atlas (TCGA) and RNA-seq data revealed that high ADAMTS6 expression in gastric cancer patients associated with poor clinical outcome and reliably predicted overall survival (Zhu et al., 2021). The gene discussed is ADAMTS6; the disease is gastric cancer.